XIST and colorectal carcinoma: Mechanistically, in vivo studies revealed out that XIST restrained 5-FU–induced cytotoxicity by promoting thymidylate synthase, a pivotal target of 5-FU.106 Similarly, both tissue and serum MEG3 were downregulated in oxaliplatin-resistant CRC patients.